Valeo Financial Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

Valeo Financial Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,000	Closed	-$4.57K	–	686
2023 Q2	$4.57K	Hold	30,000	–	–	﹤0.01%	591
2023 Q1	$4.3K	Hold	30,000	–	–	﹤0.01%	614
2022 Q4	$3.6K	Buy	+30,000	New	+$4.33K	﹤0.01%	540

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Valeo Financial Advisors's HGEN Position: Q3 2023 in Review

Valeo Financial Advisors sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 30,000 shares — an estimated $4.57K sold.

Valeo Financial Advisors first reported a position in HGEN in Q4 2022 and held it in 3 quarters. The position peaked at $4.57K in Q2 2023. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Valeo Financial Advisors reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Valeo Financial Advisors sold 30,000 HUMANIGEN, INC. shares in Q3 2023, an estimated $4.57K.
Valeo Financial Advisors first reported a position in HUMANIGEN, INC. in Q4 2022 and held it in 3 quarters.
Valeo Financial Advisors's HUMANIGEN, INC. position peaked at $4.57K in Q2 2023.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Valeo Financial Advisors's 13F filing for Q3 2023, filed 20 Oct 2023.